Patient Name: Morton Zank 
Age: 65

CC: Chest Pain

HPI: The patient, a 65-year-old male with a past medical history of hypertension and hyperlipidemia, presents to the emergency department with a chief complaint of chest pain. The pain started suddenly approximately 2 hours ago while the patient was at rest. He describes the pain as a crushing sensation in the center of his chest, radiating to his left arm and jaw. The pain is associated with shortness of breath and diaphoresis. The patient denies any other associated symptoms such as nausea, vomiting, or dizziness. He has never experienced this type of pain before. The patient is concerned as his father had a myocardial infarction at the age of 60. 

ROS:
- General: No fever, weight loss, or fatigue.
- Head: No headache or trauma.
- Eyes: No visual changes or eye pain.
- Cardiovascular: Chest pain as described above. No palpitations or orthopnea.
- Pulm: Shortness of breath associated with chest pain. No cough or wheezing.
- GI: No abdominal pain, nausea, vomiting, or changes in bowel movements.
- GU: No changes in urinary frequency, urgency, or hematuria.
- Musculoskeletal: No joint pain or swelling.
- Neurologic: No changes in sensation, strength, or coordination. No headache or dizziness.
- Endocrine: No polydipsia, polyuria, or weight changes.
- Skin: No rash, itching, or discoloration.

PMHx: 
- Hypertension
- Hyperlipidemia

Medications:
- Lisinopril 10 mg daily
- Atorvastatin 40 mg daily

PSurgHx: No previous surgeries.

FamHx:
- Father with history of myocardial infarction at age 60.
- Mother with history of hypertension.

SocHx: The patient is a retired accountant. He is married and lives with his wife. He denies tobacco, alcohol, or illicit drug use. His exercise consists of brisk walking for 30 minutes, 3 times a week. He has a balanced diet and follows a low-salt and low-fat regimen.

As a physician in the emergency department, further assessment and investigations will be required to evaluate the patient for acute coronary syndrome. This will include an electrocardiogram, cardiac biomarkers, and further risk stratification. The patient will be closely monitored for any changes in his cardiac status and treated accordingly.